Neurostimulation: Market Research Report

January 2015 | 220 pages | ID: N1A668873E5EN
Global Industry Analysts, Inc

Abstracts

This report analyzes the worldwide markets for Neurostimulation in US$ by the following Product Segments: Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS), Vagus Nerve Stimulators (VNS), and Gastric Electric Stimulators (GES). The United States is analyzed both in terms of value (US$) and volume (units) sales. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 30 companies including many key and niche players such as -

• Aleva Neurotherapeutics SA
• BioControl Medical
• Bioness Inc.
• Boston Scientific Corp.
• EnteroMedics Inc.

Contents

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations
Disclaimers
Data Interpretation & Reporting Level
Quantitative Techniques & Analytics
Product Definitions and Scope of Study
Spinal Cord Stimulation (SCS)
Deep Brain Stimulation (DBS)
Sacral Nerve Stimulation (SNS)
Vagus Nerve Stimulation (VNS)
Gastric Electric Stimulation (GES)

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

Market Primer
Major Neurostimulation Therapies and Indications At A Glance
Outlook

Table 1. Global Neurostimulation Market - Product Segments Ranked by CAGR (Value Sales) for 2014-2020: Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS), Vagus Nerve Stimulators (VNS), and Gastric Electric Stimulators (GES) (includes corresponding Graph/Chart)

Developed Markets: Traditional Revenue Contributors
Developing Countries Turbo Charge Future Market Growth

Table 2. Global Neurostimulation Market - Geographic Regions Ranked by CAGR (Value Sales) for 2014-2020: Asia-Pacific, Latin America, Rest of World, Europe, Japan, US, and Canada (includes corresponding Graph/Chart)

Spinal Cord Stimulation (SCS): A Rapidly Evolving Market

2. COMPETITIVE SCENARIO

Few Players Dominate Neurostimulation Market
Worldwide Neurostimulation Market: Leading Players by Product Segment

Table 3. Leading Players in the Global Neurostimulation Devices Market (2014): Percentage Share Breakdown of Value Sales for Medtronic, Boston Scientific, St. Jude Medical, Cyberonics and Others (includes corresponding Graph/Chart)

FDA-Approved Products of Leading Players in the Neurostimulation Market
Select Neuromodulation Products under Development
Companies Researching Neurostimulator Applications by Indication
Competition in the PNS Space

3. GROWTH DRIVERS, TRENDS, & ISSUES

New Indications Expand Opportunities for Growth
Growing Awareness and Acceptance Among Physicians
Neuropathic Pain: A Highly Underserved Market
Peripheral Nerve Stimulation (PNS): A Potential Area for Pain Management Devices
Occipital Nerve Stimulation (ONS): An Untapped Market with Potential
Steering Brain Stimulation – An Emerging Concept in DBS
Novel Applications Bode Tremendous Prospects
Obesity Control to Spur Market Growth in Future

Table 4. Obese and Overweight, and Obese Population in the World (2013): Percentage Share Breakdown by Region for US, European Union, and Rest of World (includes corresponding Graph/Chart)

Table 5. Global Obesity Population by Region/Country: 2013 (includes corresponding Graph/Chart)

Powering Neurostimulation Devices- The Key to Success
Closed-Loop Functionality Gaining Favor over Open-Loop in Neurostimulation
Device Programmability Gains Precedence in Device Choice
Novel Electrode Configurations Aid in Localization and Side Effect Reduction
Advances in Programming Promise Ease of Treatment
Vagus Nerve Stimulation for Treating Obesity
Trigeminal Nerve Stimulation – A Promising Area
Nanotechnology – The Future of DBS Electrodes
Synergy with Pharma & Biotech Companies Creates New Avenues
Third-Party Reimbursement – A Vital Role to Play
Outsourcing – A Growing Phenomenon
Chip Makers Struggle to Meet Quality Demand
Product Complexity: A Cause of Concern
Concerns Remain Afloat – Affecting Adoption
Hardware-related Infections – A Major Concern
Battery Life – A Bone of Contention for Neurostimulation
Neurostimulation Market Marked by High Entry Barriers

4. MACRO GROWTH DRIVERS FOR NEUROSTIMULATION INDUSTRY

Ballooning Global Population Offers Significant Growth Opportunities

Table 6. Top 25 Countries Worldwide in Terms of Population (2010 & 2013) (includes corresponding Graph/Chart)

Aging Global Population: A Major Growth Propeller
Demographic Statistics of Aging Populace: Unfurling the Market Potential

Table 7. Aging (65+) Demographics as a Percentage of Total Population for Major Countries: 2000, 2011, and 2020 (includes corresponding Graph/Chart)

Table 8. Global Aging Population (in Thousands) by Age Group: 1975, 2000, 2025, and 2050 (includes corresponding Graph/Chart)

Table 9. Global Population Statistics for 65+ Age Group (2014) (includes corresponding Graph/Chart)

Longer Life Expectancy Bolsters Market Growth

Table 10. Life Expectancy for Select Countries in Number of Years (2015E) (includes corresponding Graph/Chart)

Table 11. Global Life Expectancy at Age 60 and 80 Years: 2010-2015; 2020-2025; and 2045-2050 (includes corresponding Graph/Chart)

Rising Disposable Incomes Propel Market Growth

Table 12. Annual Disposable Incomes in US$ Thousand for Select Countries (2012) (includes corresponding Graph/Chart)

Table 13. Global Middle Class Population (in Millions) by Geographic Region: 2010, 2020P & 2030P (includes corresponding Graph/Chart)

Improving Healthcare Expenditure to Foster Growth

Table 14. Per-Capita Healthcare Expenditure in Select Regions (2013) (includes corresponding Graph/Chart)

Table 15. Healthcare Spending as a Percentage of GDP in Select Countries (2013) (includes corresponding Graph/Chart)

5. TECHNOLOGICAL ADVANCEMENTS IN NEUROSTIMULATION MARKET

RNS Assists Medical Practitioners in Treating Critical Neurological Ailments
Investigational DBS Device Inches towards Closed-Loop Functionality
Closed-Loop Stimulation – A Potential Solution for Gait Disturbances in DBS Treated PD Patients
Vagus Nerve Stimulator Offers Safe and Reliable Epilepsy Treatment for Patients
AspireSR Neurostimulator Mitigates Requirement of Brain Surgery
AspireSR Neurostimulator Gains Momentum
Medtronic’s SCS System Brings Paradigm Shift in Neurostimulators Market
Equilia System Provides Cost-Effective Treatment for Cardiovascular Patients
Portable Neuromodulation Device to Improve Walking in Multiple Sclerosis Patients
Emerging PNS Technologies to Drive Neuromodulation Device Market
Mainstay ReActive8
SMARTPATCH PNS System from SPR Therapeutics
Neuros Medical’s Electrical Nerve Block Technology
I-Patch from Direct Spinal Therapeutics
Valtronic and NDI Medical to Develop Miniature Implantable Pulse Generator
Neuromodulation Device for Obstructive Sleep Apnea Treatment
SetPoint Medical’s Vagus Nerve Stimulation Technology
Other Potential Applications for PNS Technology

6. SELECT TARGETED INDICATIONS

Parkinson’s Disease – The Largest Application Market for DBS
A Note on Incidence and Prevalence of Parkinson’s Disease

Table 16. Global Prevalence of Parkinson’s Disease (2014): Number of Patients Affected in Thousands for Select Countries/Regions (includes corresponding Graph/Chart)

Research Suggests Greater Benefits of DBS in Parkinson’s
Incidence and Prevalence of Essential Tremor
DBS in Dystonia
Clinical Evidence of DBS in Dystonia: An Overview of Results from Select Clinical Studies and Meta-Analyses
Dystonia Patient Selection Criteria for DBS
DBS in OCD
DBS in Epilepsy Treatment

Table 17. Global Prevalence of Epilepsy (2014): Number of Patients Affected in Thousands for Select Countries/Regions (includes corresponding Graph/Chart)

DBS in Tourette Syndrome – Research Progress So Far
Clinical Evidence of DBS in Tourette Syndrome: An Overview of Results from Select Clinical Studies and Meta-Analyses
Paucity of Effective Drugs Drives Shift in Psychiatric Disorder Treatment
Multiple Possible Targets Deter Progress of DBS in Depression Treatment
Overview of Select Studies on DBS in Depression Treatment
SCC – A Promising Target for Stimulation in Depression
Eating Disorders - A Note on Potential of DBS
DBS in Obesity – Animal Models Show Promise
Anorexia Treatment – Where Does DBS Stand?
DBS in Dementia Treatment – Animal Studies Bode Well for Efficacy in Humans
Prospects of DBS in Chronic Pain Management
SNS for Incontinence
Types of Incontinence and Features/Causes for Incontinence

Table 18. Worldwide Prevalence (%) of Urinary Incontinence in Men and Women (includes corresponding Graph/Chart)

Table 19. Worldwide Prevalence of Stress UI in Women in the Age Group of 15 to 85+ Years by Select Geographic Region: 2013-2020 (includes corresponding Graph/Chart)

Sleep Apnea

7. PRODUCT OVERVIEW

Introduction to Neurostimulator
A Historical Note
Neurostimulation Devices by Product Segment
Spinal Cord Stimulation (SCS)
SCS – What it Treats
Segmentation by Type of Power Source
Implantable Pulse Generator Systems (IPGs)
Radio Frequency (RF) Systems
Market Assessment for RF Systems
Sacral Nerve Stimulation (SNS)
Deep Brain Stimulation (DBS)
Vagus Nerve Stimulation (VNS)
Gastric Electric Stimulation (GES)
Stimulation Device – How it Works
Neurostimulation & its Benefits
Prospective Application Areas for Neurostimulators – Select Indications
Approved Indications for Spinal Cord Stimulation by Geographic Regions
Neurostimulation Devices – Technology & Safety Issues

8. NEUROSTIMULATION DEVICE APPROVALS

St. Jude Medical Wins CE Mark Approval for MR- Conditional Rechargeable Spinal Cord Stimulator
St. Jude Medical Nabs CE Mark for Infinity Deep Brain Stimulation System and Directional DBS Lead
EndoStim Receives CE Mark Approval for EndoStim II
St. Jude Medical Wins Health Canada Approval for Prodigy Spinal Cord Stimulator
St. Jude Medical Bags FDA Approval for Brio Neurostimulation System for Parkinson's Disease
Medtronic Receives European Approval of Full-Body MR Conditional Deep Brain Stimulation Systems
AdvaStim Gets Neurostimulation Patent
St. Jude Bags EU Regulatory Approval for Prodigy Neurostimulator with Burst Technology
St. Jude Medical Secures FDA Approval for Protege IPG

9. PRODUCT INNOVATIONS/INTRODUCTIONS

NeuroMetrix Introduces Quell Wearable Pain Relief Technology
NeuroMetrix Unveils SENSUS Pain Management System
Medtronic Rolls Out Neurostimulation Systems for Chronic Pain

10. RECENT INDUSTRY ACTIVITY

St. Jude Medical Snaps Up Spinal Modulation
Allergan Acquires Oculeve
Medtronic Takes Over Advanced Uro-Solutions
Sorin and Cyberonics Announces Merger
Greatbatch Spins Off Algostim
Medtronic Takes Over Sapiens Steering Brain Stimulation
Kelyniam Global Snaps Up MED-ALLY
AdvaStim Forays into Neuromodulation Device Market
Aurora BioScience Inks Distribution Agreement with Synapse Biomedical
Sorin Group Acquires Neurotech
St Jude Medical and Spinal Modulation Ink Distribution Agreements
Boston Scientific Commences Trial for Neurostimulation Evaluation in Chronic Migraine Treatment
Spinal Modulation Starts Trial for Neurostim Device

11. FOCUS ON SELECT PLAYERS

Aleva Neurotherapeutics SA (Switzerland)
BioControl Medical (Israel)
Bioness Inc. (USA)
Boston Scientific Corp. (USA)
EnteroMedics Inc. (USA)
LivaNova PLC (UK)
Medtronic, Inc. (USA)
NeuroPace, Inc. (USA)
NeuroSigma, Inc. (USA)
Nevro Corp. (USA)
SPR Therapeutics, LLC (US)
St. Jude Medical, Inc. (USA)
Synapse Biomedical, Inc. (USA)

12. GLOBAL MARKET PERSPECTIVE

Table 20. World Recent Past, Current & Future Analysis for Neurostimulation Devices by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for the Years 2014 through 2020 (includes corresponding Graph/Chart)

Table 21. World Historic Review for Neurostimulation Devices by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for the Years 2007 through 2013 (includes corresponding Graph/Chart)

Table 22. World 14-Year Perspective for Neurostimulation Devices by Geographic Region - Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets for the Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

Table 23. World Recent Past, Current & Future Analysis for Spinal Cord Stimulators by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for the Years 2014 through 2020 (includes corresponding Graph/Chart)

Table 24. World Historic Review for Spinal Cord Stimulators by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for the Years 2007 through 2013 (includes corresponding Graph/Chart)

Table 25. World 14-Year Perspective for Spinal Cord Stimulators by Geographic Region - Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets for the Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

Table 26. World Recent Past, Current & Future Analysis for Deep Brain Stimulators by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for the Years 2014 through 2020 (includes corresponding Graph/Chart)

Table 27. World Historic Review for Deep Brain Stimulators by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for the Years 2007 through 2013 (includes corresponding Graph/Chart)

Table 28. World 14-Year Perspective for Deep Brain Stimulators by Geographic Region - Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets for the Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

Table 29. World Recent Past, Current & Future Analysis for Sacral Nerve Stimulators by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for the Years 2014 through 2020 (includes corresponding Graph/Chart)

Table 30. World Historic Review for Sacral Nerve Stimulators by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for the Years 2007 through 2013 (includes corresponding Graph/Chart)

Table 31. World 14-Year Perspective for Sacral Nerve Stimulators by Geographic Region - Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets for the Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

Table 32. World Recent Past, Current & Future Analysis for Vagus Nerve Stimulators by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for the Years 2014 through 2020 (includes corresponding Graph/Chart)

Table 33. World Historic Review for Vagus Nerve Stimulators by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for the Years 2007 through 2013 (includes corresponding Graph/Chart)

Table 34. World 14-Year Perspective for Vagus Nerve Stimulators by Geographic Region - Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets for the Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

Table 35. World Recent Past, Current & Future Analysis for Gastric Electric Stimulators by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for the Years 2014 through 2020 (includes corresponding Graph/Chart)

Table 36. World Historic Review for Gastric Electric Stimulators by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for the Years 2007 through 2013 (includes corresponding Graph/Chart)

Table 37. World 14-Year Perspective for Gastric Electric Stimulators by Geographic Region - Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets for the Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES

A. Market Analysis
Overview
Product Segments Ranked by Growth

Table 38. Neurostimulation Market in the US (2014-2020): Product Segments Ranked by Revenue Growth (includes corresponding Graph/Chart)

Table 39. Neurostimulation Market in the US (2014-2020): Product Segments Ranked by Unit Sales Growth (includes corresponding Graph/Chart)

Neurostimulation Indications and Use of Related Devices/Techniques in the US
Potential Growth for Neurostimulation Systems in the US
Spinal Cord Stimulation Products Market
Sacral Nerve Stimulation Products Market
Deep Brain Stimulation Products Market
Aging Baby Boomers Benefit Market Prospects in the US

Table 40. North American Elderly Population by Age Group: 1975, 2000, 2025P, and 2050P (includes corresponding Graph/Chart)

Shift Away from Orthopaedic and Cardiovascular Device Markets
Trends in the Embolotherapy Market
Neurovascular Stents Market Attracting Cardiovascular Companies
Migraine Devices – New Frontiers for Neurostimulation
Competitive Landscape
Neurostimulation Device Approvals
Product Innovations/Introductions
Strategic Corporate Developments
Select Key Players
B. Market Analytics

Table 41. US Recent Past, Current & Future Analysis for Neurostimulation Devices by Product Segment - Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS), Vagus Nerve Stimulators (VNS), and Gastric Electric Stimulators (GES) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)

Table 42. US Historic Review for Neurostimulation Devices by Product Segment - Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS), Vagus Nerve Stimulators (VNS), and Gastric Electric Stimulators (GES) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)

Table 43. US 14-Year Perspective for Neurostimulation Devices by Product Segment - Percentage Breakdown of Value Sales for Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS), Vagus Nerve Stimulators (VNS), and Gastric Electric Stimulators (GES) Markets for the Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

Table 44. US Recent Past, Current & Future Analysis for Neurostimulation Devices by Product Segment - Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS), Vagus Nerve Stimulators (VNS), and Gastric Electric Stimulators (GES) Markets Independently Analyzed with Annual Sales Figures in Units for Years 2014 through 2020 (includes corresponding Graph/Chart)

Table 45. US Historic Review for Neurostimulation Devices by Product Segment - Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS), Vagus Nerve Stimulators (VNS), and Gastric Electric Stimulators (GES) Markets Independently Analyzed with Annual Sales Figures in Units for Years 2007 through 2013 (includes corresponding Graph/Chart)

Table 46. US 14-Year Perspective for Neurostimulation Devices by Product Segment - Percentage Breakdown of Unit Sales for Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS), Vagus Nerve Stimulators (VNS), and Gastric Electric Stimulators (GES) Markets for the Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

2. CANADA

A. Market Analysis
Outlook
Neurostimulation Device Approval
B. Market Analytics

Table 47. Canadian Recent Past, Current & Future Analysis for Neurostimulation Devices by Product Segment - Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS), Vagus Nerve Stimulators (VNS), and Gastric Electric Stimulators (GES) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)

Table 48. Canadian Historic Review for Neurostimulation Devices by Product Segment - Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS), Vagus Nerve Stimulators (VNS), and Gastric Electric Stimulators (GES) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)

Table 49. Canadian 14-Year Perspective for Neurostimulation Devices by Product Segment - Percentage Breakdown of Value Sales for Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS), Vagus Nerve Stimulators (VNS), and Gastric Electric Stimulators (GES) Markets for the Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

3. JAPAN

Market Analysis

Table 50. Japanese Recent Past, Current & Future Analysis for Neurostimulation Devices by Product Segment - Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS), Vagus Nerve Stimulators (VNS), and Gastric Electric Stimulators (GES) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)

Table 51. Japanese Historic Review for Neurostimulation Devices by Product Segment - Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS), Vagus Nerve Stimulators (VNS), and Gastric Electric Stimulators (GES) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)

Table 52. Japanese 14-Year Perspective for Neurostimulation Devices by Product Segment - Percentage Breakdown of Value Sales for Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS), Vagus Nerve Stimulators (VNS), and Gastric Electric Stimulators (GES) Markets for the Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

4. EUROPE

A. Market Analysis
Outlook
Increasing Incidence of Neurological Diseases Spur Market Growth
Rising Life Expectancy and the Risk of Injury to Drive Demand across Europe

Table 53. Life Expectancy at 65 Years for Select Countries in Europe: 2012 (includes corresponding Graph/Chart)

Table 54. European Country-wise Statistics of 60+ Population as % of Total Population: 2013 (includes corresponding Graph/Chart)

Neurostimulation Device Approvals
Strategic Corporate Developments
Select Key Players
B. Market Analytics

Table 55. European Recent Past, Current & Future Analysis for Neurostimulation Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)

Table 56. European Historic Analysis for Neurostimulation Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)

Table 57. European 14-Year Perspective for Neurostimulation Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

Table 58. European Recent Past, Current & Future Analysis for Neurostimulation Devices by Product Segment - Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS), Vagus Nerve Stimulators (VNS), and Gastric Electric Stimulators (GES) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)

Table 59. European Historic Review for Neurostimulation Devices by Product Segment - Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS), Vagus Nerve Stimulators (VNS), and Gastric Electric Stimulators (GES) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)

Table 60. European 14-Year Perspective for Neurostimulation Devices by Product Segment - Percentage Breakdown of Value Sales for Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS), Vagus Nerve Stimulators (VNS), and Gastric Electric Stimulators (GES) Markets for the Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

5. ASIA-PACIFIC

A. Market Analysis
Outlook
Neurostimulation Devices Market Exhibits Substantial Growth
Strategic Corporate Development
B. Market Analytics

Table 61. Asia-Pacific Recent Past, Current & Future Analysis for Neurostimulation Devices by Geographic Region - China, India and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)

Table 62. Asia-Pacific Historic Analysis for Neurostimulation Devices by Geographic Region - China, India and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)

Table 63. Asia-Pacific 14-Year Perspective for Neurostimulation Devices by Geographic Region - Percentage Breakdown of Value Sales for China, India and Rest of Asia-Pacific Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

Table 64. Asia-Pacific Recent Past, Current & Future Analysis for Neurostimulation Devices by Product Segment - Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS), Vagus Nerve Stimulators (VNS), and Gastric Electric Stimulators (GES) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)

Table 65. Asia-Pacific Historic Review for Neurostimulation Devices by Product Segment - Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS), Vagus Nerve Stimulators (VNS), and Gastric Electric Stimulators (GES) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)

Table 66. Asia-Pacific 14-Year Perspective for Neurostimulation Devices by Product Segment - Percentage Breakdown of Value Sales for Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS), Vagus Nerve Stimulators (VNS), and Gastric Electric Stimulators (GES) Markets for the Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

6. LATIN AMERICA

Market Analysis

Table 67. Latin American Recent Past, Current & Future Analysis for Neurostimulation Devices by Geographic Region - Brazil and Rest of Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)

Table 68. Latin American Historic Analysis for Neurostimulation Devices by Geographic Region - Brazil and Rest of Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)

Table 69. Latin American 14-Year Perspective for Neurostimulation Devices by Geographic Region - Percentage Breakdown of Value Sales for Brazil and Rest of Latin America Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

Table 70. Latin American Recent Past, Current & Future Analysis for Neurostimulation Devices by Product Segment - Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS), Vagus Nerve Stimulators (VNS), and Gastric Electric Stimulators (GES) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)

Table 71. Latin American Historic Review for Neurostimulation Devices by Product Segment - Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS), Vagus Nerve Stimulators (VNS), and Gastric Electric Stimulators (GES) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)

Table 72. Latin American 14-Year Perspective for Neurostimulation Devices by Product Segment - Percentage Breakdown of Value Sales for Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS), Vagus Nerve Stimulators (VNS), and Gastric Electric Stimulators (GES) Markets for the Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

7. REST OF WORLD

A. Market Analysis
Outlook
Business-Friendly Government Policies Fuels Market Growth
BioControl Medical – A Major Israeli Player
B. Market Analytics

Table 73. Rest of World Recent Past, Current & Future Analysis for Neurostimulation Devices by Product Segment - Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS), Vagus Nerve Stimulators (VNS), and Gastric Electric Stimulators (GES) Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)

Table 74. Rest of World Historic Review for Neurostimulation Devices by Product Segment - Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS), Vagus Nerve Stimulators (VNS), and Gastric Electric Stimulators (GES) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)

Table 75. Rest of World 14-Year Perspective for Neurostimulation Devices by Product Segment - Percentage Breakdown of Value Sales for Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS), Vagus Nerve Stimulators (VNS), and Gastric Electric Stimulators (GES) Markets for the Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

IV. COMPETITIVE LANDSCAPE

Total Companies Profiled: 30 (including Divisions/Subsidiaries - 31)
The United States (23)
Europe (7)
  Germany (2)
  The United Kingdom (2)
  Rest of Europe (3)
Middle East (1)